2025

APRIL 1-3, 2025 ​​​​​​​| JAVITS CENTER, NYC

Your Gateway to Pharmaceutical and Biotechnology Innovation

Welcoming over 9,000 industry professionals from across the globe, INTERPHEX is the ultimate meeting point for innovation, collaboration, and learning in the pharmaceutical and biotechnology sectors. Taking place April 1-3, 2025, at the iconic Javits Center in New York City, INTERPHEX is an unparalleled platform for industry leaders, researchers, and professionals to engage in meaningful discussions shaping the future of healthcare.

Why Attend INTERPHEX?

A Hub of Innovation and Networking

At its core, INTERPHEX is a space where knowledge meets opportunity. The event shines as a beacon of connectivity, offering attendees the chance to network with peers, meet industry pioneers, and discuss the latest trends and breakthroughs in pharmaceutical and biotechnology fields. Whether you're a scientist, researcher, engineer, or a pharmaceutical professional, you'll find sessions and exhibits tailored to your needs and expertise.

Interactive Exhibition Floor

The exhibition floor is at the heart of INTERPHEX, showcasing state-of-the-art products and services from global industry leaders. Encompassing advanced manufacturing technologies, cutting-edge AI-driven process innovations, and new drug development techniques, the exhibits provide a hands-on glimpse into the future of the industry. From continuous manufacturing equipment to predictive data analytics tools, you’ll leave with actionable insights and ideas.

Expert-Led Conferences

Dive deeper into industry challenges and solutions with INTERPHEX's renowned educational sessions. The Learning Lab hosts over 30 hours of content, featuring 106 global speakers across 56 curated sessions. Keynote speeches by leading scientists, quick-fire presentations on the latest research, and dynamic panel discussions create an educational experience perfectly suited for increasing your professional knowledge. Themes like “Advanced Manufacturing” and “Ensuring Access to Innovative Medicines” will empower you with the tools and ideas to solve real-world problems.

Community and Engagement

Community is a significant aspect of INTERPHEX. Join exclusive events like the Networking Lounge, New Exhibitor Happy Hour, Contract Pavilion Happy Hour, and OUTbio Reception. These are fantastic opportunities to connect with like-minded professionals, form partnerships, and expand your footprint in the industry.

A World-Class Venue

The Javits Center in New York City serves as the perfect backdrop for INTERPHEX 2025. Known for its advanced facilities and central location in Manhattan, the venue ensures a seamless experience for all attendees. Its proximity to NYC's cultural landmarks and dining hotspots also makes your visit even more enriching.

Why This Event Matters

INTERPHEX goes beyond simply showcasing products and sharing knowledge; it’s about empowering attendees to make a tangible impact on their careers and businesses. By attending, you'll enhance your professional development, accelerate business growth, and stay competitive in a field that's constantly evolving. It’s the perfect platform to gain a competitive edge in an industry where innovation drives success.

Don’t Miss Out!

Prepare to elevate your industry expertise and build meaningful connections. Secure your place at INTERPHEX 2025 today and ensure you're at the forefront of pharmaceutical and biotechnology innovation. Visit the official website to register and learn more about this unmissable event!

Go to article: Home | US reproductive laws could limit women’s participation in clinical trialsGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: Avenga Company InsightGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: InterphexGo to article: Investment and Development Agency of Latvia Company InsightGo to article: In DepthGo to article: US reproductive laws could limit women’s participation in clinical trialsGo to article: How Pfizer management outplayed activist investor StarboardGo to article: Trump 2.0 spells global change in pharmaceutical regulation, funding and investmentGo to article: Flu vaccine strategy on the line as new US leaders anticipated to take chargeGo to article: Lilly’s £279m bet aims to boost UK life sciences sectorGo to article: PrEP therapies offer new hope in HIV preventive landscape as vaccine failures amassGo to article: DatwylerGo to article: Pharma Event GuideGo to article: In this guideGo to article: Avenga Company InsightGo to article: AST Company InsightGo to article: ICROM Company InsightGo to article: Girteka Company InsightGo to article: 2024 Event HighlightsGo to article: Swiss biotech ecosystem recuperates from global financial instabilityGo to article: Cell and gene therapy approvals drive paradigm change in manufacturingGo to article: Will the tide turn for the wave of pharma layoffs?Go to article: AIDS 24: Prioritise at risk populations for trials, testing and treatmentGo to article: Pharma readies for climate disasters amidst supply chain concernsGo to article: Amgen showcases exciting potential in the obesity space at JPM24 Go to article: Experts call for a shift from reactive to proactive clinical trial supply frameworksGo to article: 2025 Event CalendarGo to article: InterphexGo to article: Advertise with usGo to article: ListingsGo to article: Pharmaceutical Technology Excellence Awards 2024 winnersGo to article: Buyer's GuidesGo to article: Next issue